Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Asset Utilization Ratio (2016 - 2025)

Sunshine Biopharma (SBFM) has disclosed Asset Utilization Ratio for 9 consecutive years, with 1.18 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 5.93% year-over-year to 1.18, compared with a TTM value of 1.18 through Sep 2025, up 5.93%, and an annual FY2024 reading of 1.2, up 41.46% over the prior year.
  • Asset Utilization Ratio was 1.18 for Q3 2025 at Sunshine Biopharma, down from 1.19 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.21 in Q1 2025 and bottomed at 0.01 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 0.56, with a median of 0.52 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio tumbled 85.06% in 2022, then skyrocketed 6027.84% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.1 in 2021, then grew by 27.67% to 0.12 in 2022, then surged by 606.75% to 0.88 in 2023, then soared by 31.33% to 1.15 in 2024, then rose by 2.24% to 1.18 in 2025.
  • Business Quant data shows Asset Utilization Ratio for SBFM at 1.18 in Q3 2025, 1.19 in Q2 2025, and 1.21 in Q1 2025.